Kayavate Lotion contains Clobetasol propionate 0.05% w/v, a potent topical corticosteroid indicated for the management of various inflammatory and pruritic dermatoses responsive to corticosteroid therapy. Clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing erythema, swelling, and itching. Kayavate Lotion is primarily used in conditions such as psoriasis, eczema, lichen planus, and other corticosteroid-responsive dermatoses. The formulation allows for easy application and rapid absorption into the skin, providing effective symptomatic relief. It is recommended for short-term use due to its high potency to minimize the risk of adverse effects such as skin atrophy, telangiectasia, and systemic corticosteroid absorption. Application should be limited to affected areas, avoiding prolonged or excessive use, especially on thin skin or large surface areas. Patients should be advised to avoid contact with eyes and mucous membranes. Use during pregnancy and lactation should be under medical supervision. Kayavate Lotion should be used as directed by a healthcare professional, and any signs of irritation or hypersensitivity warrant discontinuation and medical consultation. Proper adherence to prescribed duration and dosage is essential to maximize therapeutic benefits while minimizing potential risks.